Kyowa Hakko Kirin
Kyowa Hakko Kirin signs drug discovery deal with AI firm InveniAI
January 11, 2019Medical Communications, Research and Development AI, InveniAI, Kyowa Hakko Kirin, artificial intelligence, drug discovery, pharma
Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …
BMS to trial Opdivo in solid tumours
July 30, 2015Research and Development BMS, Bristol-Myers Squibb, Kyowa Hakko Kirin, Poteligeo, mogamulizumab, nivolumab, opdivo, solid tumours
Bristol-Myers Squibb will begin early-phase trials of its immuno-oncology treatment Opdivo with other cancer treatments, to see if the combination …
New $50m plant unveiled by Kyowa Hakko Kirin
July 12, 2011Manufacturing and Production Kyowa Hakko Kirin, pharma manufacturing news
Japan’s Kyowa Hakko Kirin is to build a new manufacturing unit for oral formulations at its main production facility in …
Scottish biotech ProStrakan sold for £292m
February 22, 2011Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech
Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
